No UK Approval Filing For Biogen's Tofersen Because Of NICE HTA Decision

 
• By Ian Schofield

England’s health technology assessment body, NICE, says it has suspended the appraisal process for the motor neurone disease treatment while it considers the next steps. No HTA submission for tofersen has been made in Scotland.

Motor neuron connecting to muscle fiber, 3D illustration. A neuromuscular junction allows the motor neuron to transmit a signal to the muscle
Tofersen has been shown to slow the progression of motor neurone disease • Source: Shutterstock

More from Europe

More from Geography